1Charles KS,Kanaa M,Winfield DA,et al.Scro talulceration during all-trans retinoic acid (ATRA) therapy for acute promyelocytic leukemia[J].Cin Lab Haematol,2000,22(3):171.
2Mori A,Tamura S,Katsuna T,et al.Scrotal ulcer occurring in patients with acute promyelocytic leukemia during treatment with all-trans-retinoic acid[J].Oncol Rep,1999,6(1):55.
3Pavithran K,Arjun R,Aruna R,et al.Scrotal ulcertion during induction therapy of acute p romyelocytic leukemia with A TRA[J].Am J Hemato l,2004,75(4):260.
4Tajima K,Sagae M,Yahagi A,et al.Scrotum exfoliative dermatit is with ulcers associated with treatment of acute promyelocytic leukemia with all-trans-retinoic acid[J].R insho Ketsueki,1998,39(1):48.
5Simzar S,Rotunda AM,Craft N.Scrotal ulceration as a consequence of all-trans-retinoic acid(ATRA) for the treatment of acute promyelocytic leukemia[J].J D Rugs Dermatol,2005,4(2):231.
3Pinkerton CR.The continuing challenge of treatment for non-Hodgkin′s lymphoma in children[J].Bri J Haematol,1999,107(2):220-220.
4Wiemik PH, Canellos GP, Dutcher JP, et al. Neoplastic diseases of the blood[M]. 3th Ed. Churchill Livingstone: a division of Harcourt Brace & Company. 1996.1.
6Hoelzer D, Thiel E, Loffler H, et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia inadults[J]. Blood,1998.71(1): 123.
7Henderson ES, Lister TA, Greaves MF. Leukemia[M].7th Ed. Health Science Asia: Elsevier Science,2002.1.
8Sanders J,Glader B,Cairo M,et al. Guidelines for the pediatric cancer center and role of such centers in diagnosis and treatment, american academy of pediatrics section statement section on hematology/oncology [J]. Pediatrics,1997, 99(1): 139.
9Pinkerton CR. The continuing challenge of treatment for non-Hodgkin's lymphoma in children[J]. Bri J Haemato1,1999, 107(2): 220.
10Lu DP,Qiu JY,Jiang B,et al. Effective treatment of acute promyelocytic leukemia(APL) with tetra-arsenic tetra-sulfide(AS4S4), a monoinstitutional study[J]. Blood, 1999,94(Sulolol 1) :698a.
3Cohen P R. Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis [ J ]. Orphanet J Rare Dis, 2007,2:34.
4Fazili T, Duncan D, Wani L. Sweet's syndrome[J]. Am J Med, 2010,123(8) :694-696.
5Kandula S, Burke W S, Goldfarb J N. Clindamycin-in- duced Sweet syndrome [ J]. J Am Acad Dermatol, 2010, 62(5) :898-900.
6EI Moutaoui L, Zouhair K, Benchikhi H. Sweet syn- drome induced by chloroquine [ J ]. Ann Dermatol Venere- ol, 2009,136( 1 ) :56-57.
7Cohen P R, Kurzrock R. Sweet's syndrome and cancer [ J ]. Clin Dermatol, 1993,11 ( 1 ) : 149-157.
8Iland HJ,Seymour JF.Role of arsenic trioxide in acute promyelocytic leukemia[J].Curr Treatm 0ptions 0ncol,2013,14(2):170-184.
9Ahman JK,Rademaker A,cull E,et al.Administration of atra to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death[J].Leuk Res,2013,37(9):1004-1009.
